Suggestions
Michaela Miller
VP/Practice Leader, U.S. MedTech Technology & Analytics at IQVIA
Michaela Miller is a senior executive in the healthcare technology and analytics industry. She currently holds the position of VP, Practice Leader, U.S. MedTech Technology & Analytics at IQVIA, a role she has been in since January 2021.1 IQVIA is a company that specializes in healthcare data and analytics.
Professional Background
Michaela is based in Waltham, Massachusetts, United States.1 Her role at IQVIA likely involves leading strategic initiatives in medical technology and analytics for the U.S. market. Given her title, she is likely responsible for overseeing teams, developing business strategies, and driving innovation in the MedTech sector.
Skills and Expertise
Michaela has demonstrated a commitment to continuous learning and professional development, as evidenced by her recent certifications:
- Leadership: She completed a course on "Leading Effective Decision Making" from Yale School of Management in October 2023.1
- Communication: In April 2024, she earned a certification in "Communicating with Executives" from LinkedIn.1
- AI and Technology: Also in April 2024, she completed a course on "Autonomous Transformation: Create a More Human Future with AI" from LinkedIn.1
These certifications suggest that Michaela is focused on enhancing her leadership skills, improving executive communication, and staying current with AI and technological advancements in the healthcare industry.
Industry Involvement
Michaela appears to be actively engaged in industry events and discussions. She has shared posts about:
- Healthcare data, master data management, and data governance.2
- Participating in dialogues with medical device and diagnostic customer partners.3
- Sponsorship of industry events, suggesting a role in business development and networking.4
Her involvement in these areas indicates that she is at the forefront of discussions about data-driven healthcare solutions and maintains strong relationships with key stakeholders in the medical technology sector.
Highlights
The Monday before the exhibit hall officially opens at the annual ADLM conference (Association for Diagnostics & Laboratory Medicine), is always one of my favorite days. It starts off with the International Market Briefing (#IMB) and culminates with the Disruptive Technology Award Competition (#DTAC) in the later afternoon. Insightful, fun, and a great place to connect with industry friends and colleagues. Truly one of my favorite conferences and it is always nice to come back to Chicago!!!!
During the IMB, Mark Girardi and Kaitlin Vautour from IQVIA MedTech shared the latest update on the Global IVD Market, which reached $81 billion in total size in 2023. A couple of key points:
- COVID revenue accounted for an estimated 11% of the total ($9 billion), a decline compared to $49 billion in 2022, and the single largest factor influencing overall market performance.
- Excluding COVID testing, the global IVD Market showed a rebound and grew +6% LC.
- The core lab segment, appeared strong (+7% LC yoy).
- Looking forward, the team expects a +3% CAGR through the next five years, +5% excluding COVID testing and driven by growth in APAC and LATAM.
- A deep-dive into the India IVD Market and associated market dynamics led to an interesting overview. The team predicted 5-year revenue growth to be around +15% CAGR in India. Great presentation and job well done team!
The Disruptive Technology Award Competition in the afternoon proved to be exciting once again with strong presentations and innovation showcased by Mercy BioAnalytics, Inc., Vitestro, and Dionysis Digital Health . Congratulations to all the finalists. In the end, Mercy Bioanalytics won the competition and the judge’s vote for its early-stage ovarian cancer test. The audience vote and winner was Vitestro with the commercialization of an automated phlebotomy system. It was exciting to see some of the innovation that is taking place in this space take center stage and it was an honor to once again serve on the Committee of the event this year. Can’t wait to see where we go next.
So overall – a great day and a wonderful opportunity to connect live with industry friends and colleagues!!! Can’t wait to see what the remainder of the conference has in store! Cheers!
In the most recent MedTech Business Insights Podcast, I had the opportunity to speak with Dr. Shelly Nash, Senior Vice President and Global Chief Medical Information Officer at Fresenius Medical Care about the important issue of Health Equity. We discussed providing equitable access to care with a focus on the use of technology and data. Dr. Nash, a physician with an impressive background in healthcare technology and medical informatics, highlighted the importance of addressing social determinants of health and the role of MedTech companies in promoting Health Equity. She also discussed the challenges faced in this journey, including the need for top-down alignment, staff training, system changes, and data management.
Thank you, Shelly, for diving into this topic with me and making this an insightful and meaningful 20 min session. For anybody who is interested in learning more given the increasing demands on demonstrating access to care, you can learn from Shelly here.
#HealthEquity #IQVIAMedTech
